Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$235K Hold
2,069
0.02% 151
2024
Q2
$256K Hold
2,069
0.03% 137
2024
Q1
$273K Sell
2,069
-297
-13% -$36.6K 0.03% 124
2023
Q4
$258K Buy
2,366
+421
+22% +$43.7K 0.03% 125
2023
Q3
$200K Buy
+1,945
New +$210K 0.03% 131
2022
Q3
Sell
-2,852
Closed -$260K 128
2022
Q2
$260K Buy
2,852
+255
+10% +$22.6K 0.05% 103
2022
Q1
$213K Buy
+2,597
New +$205K 0.04% 126
2021
Q4
Sell
-2,882
Closed -$216K 158
2021
Q3
$216K Sell
2,882
-891
-24% -$67.8K 0.04% 154
2021
Q2
$293K Sell
3,773
-2,842
-43% -$211K 0.06% 137
2021
Q1
$487K Sell
6,615
-4,178
-39% -$308K 0.11% 118
2020
Q4
$842K Buy
10,793
+1,670
+18% +$128K 0.21% 89
2020
Q3
$722K Sell
9,123
-69
-0.8% -$5.41K 0.22% 88
2020
Q2
$678K Buy
9,192
+2,846
+45% +$214K 0.22% 90
2020
Q1
$466K Buy
6,346
+2,898
+84% +$228K 0.18% 92
2019
Q4
$299K Buy
+3,448
New +$283K 0.09% 143
2017
Q4
Sell
-13,857
Closed -$847K 162
2017
Q3
$847K Buy
13,857
+581
+4% +$35.2K 0.19% 122
2017
Q2
$812K Buy
13,276
+304
+2% +$18.5K 0.22% 116
2017
Q1
$786K Sell
12,972
-7
-0.1% -$425 0.32% 84
2016
Q4
$729K Buy
12,979
+674
+5% +$39.4K 0.32% 83
2016
Q3
$733K Buy
12,305
+70
+0.6% +$4.09K 0.35% 75
2016
Q2
$673K Buy
12,235
+1,582
+15% +$84.2K 0.35% 76
2016
Q1
$538K Buy
+10,653
New +$522K 0.29% 86

Other funds holding MRK

Pegasus Partners's MRK Position: Q3 2024 in Review

Pegasus Partners held its Merck (MRK) position steady in Q3 2024 at 2,069 shares worth $235K. The position accounts for 0.02% of the portfolio, ranked #151.

Pegasus Partners first reported a position in MRK in Q1 2016 and has held it in 22 quarters since. The position peaked at $847K in Q3 2017. 3,489 funds tracked by Wall St. Rank hold MRK as of Q3 2024.

  • Pegasus Partners held 2,069 shares of Merck worth $235K as of Q3 2024.
  • Pegasus Partners left its Merck share count unchanged in Q3 2024.
  • Merck made up 0.02% of Pegasus Partners's portfolio in Q3 2024, its #151 holding.
  • Pegasus Partners first reported a position in Merck in Q1 2016 and has held it in 22 quarters since.
  • Pegasus Partners's Merck position peaked at $847K in Q3 2017.
  • 3,489 funds tracked by Wall St. Rank held Merck as of Q3 2024.

Based on Pegasus Partners's 13F filing for Q3 2024, filed 1 Nov 2024.